Donald Cutlip

Showing 1-14 of 14 articles

Author Chun Chang

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Author Chun Chang

Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

September 3, 2019 | 10.4244/EIJ-D-19-00552

Author Giulio Stefanini

Sorting out coronary stents, as time goes by

Stefanini G, Cutlip D

December 20, 2017 | 10.4244/EIJV13I11A198

Author Arie-Pieter Kappetein

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

Kappetein AP, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M

November 20, 2012 | 10.4244/EIJV8I7A121

Author Giuseppe De Luca

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Author Pascal Vranckx

Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population

Vranckx P, McFadden E, Mehran R, Cutlip D

July 27, 2012 | 10.4244/EIJV8I3A56

Author Pascal Vranckx

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P

February 25, 2010

Author Ian T. Meredith

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

Meredith I, Worthley S, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins G, Hendriks R, Matsis P, Muller D, Cutlip D

January 15, 2010

Author Nicolo Piazza

Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions

Piazza N, Cutlip D, Onuma Y, Kappetein AP, de Jaegere P, Serruys P

May 19, 2009

Author Pascal Vranckx

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

Vranckx P, Kint P-P, Morel M, Van Es G-A, Serruys P, Cutlip D

August 20, 2008

Author Joost Daemen

An introduction to "A critical appraisal of the safety concerns tempering the success of drug-eluting stents"

Daemen J, Cutlip D, Windecker S

August 20, 2008

Author Ian T. Meredith

The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial

Meredith I, Worthley S, Whitbourn R, Walters D, Popma J, Cutlip D, Fitzgerald P

May 22, 2007

Author David R Holmes

Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial

Holmes DR, Coolong A, O’ Shaughnessy C, Chauhan M, van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma J, Cutlip D, Kuntz R

August 20, 2006

Author Ian T. Meredith

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial

Meredith I, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma J, Cutlip D, Fitzgerald P, Prpic R, Kuntz R

August 20, 2005

1

Latest news

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

January 17, 2020

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke